Mitoxantrone Export Market Intelligence: India's 42 Suppliers Shipping to 35 Countries — TransData Nexus 2026

Q: Who are the top mitoxantrone exporters from India?

The top mitoxantrone exporters from India are: 1. MVL GLOBAL — $887.6K (47.0% market share); 2. INTAS PHARMACEUTICALS LIMITED — $701.0K (37.1% market share); 3. MEDWISE OVERSEAS PRIVATE LIMITED — $76.3K (4.0% market share); 4. SP ACCURE LABS PRIVATE LIMITED — $27.3K (1.4% market share); 5. CHANDRA BHAGAT PHARMA LIMITED — $18.3K (1.0% market share). Together they account for 90.6% of India's total mitoxantrone export value.

Q: What is the total export value of mitoxantrone from India?

The total export value of mitoxantrone from India is $1.9M USD, recorded across 110 shipment transactions from 42 active exporters to 35 destination countries. The average shipment value is $17.2K.

Q: Which countries import mitoxantrone from India?

India exports mitoxantrone to 35 countries worldwide. The top importing countries are: NAMIBIA (47.0% share, $887.6K), MEXICO (31.0% share, $585.1K), VENEZUELA (4.1% share, $77.4K), NETHERLANDS (3.8% share, $72.5K), TAIWAN (3.7% share, $69.8K). These five markets account for 89.7% of total export value.

Q: What is the HS code for mitoxantrone exports from India?

The primary HS code for mitoxantrone exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of mitoxantrone exports from India?

The average unit price for mitoxantrone exports from India is $38.26 USD per unit, with prices ranging from $1.05 to $1470.58 depending on formulation, packaging, and order volume. The total market is valued at $1.9M across 110 shipments.

Q: Which ports handle mitoxantrone exports from India?

The primary ports for mitoxantrone exports from India are SAHAR AIR CARGO ACC (INBOM4) (25.5% of shipments), SAHAR AIR (25.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (12.7% of shipments), Bombay Air (6.4% of shipments), DELHI AIR (3.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of mitoxantrone?

India is one of the world's leading exporters of mitoxantrone due to its large base of 42 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports mitoxantrone to 35 countries, demonstrating 18% global market coverage.

Q: What certifications do Indian mitoxantrone exporters need?

Indian mitoxantrone exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import mitoxantrone from India?

There are 56 registered buyers importing mitoxantrone from India, spread across 35 countries. The repeat buyer rate is 48.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top mitoxantrone supplier from India?

MVL GLOBAL is the leading mitoxantrone exporter from India with a market share of 47.0% and total export value of $887.6K across 3 shipments. The top 5 suppliers together control 90.6% of total export value.

Suresh Sormare

Mitoxantrone

India Pharmaceutical Trade Intelligence

$1.9M42 Suppliers35 CountriesHS 30049049

ExportsIndia → NAMIBIA47.0%India → MEXICO31.0%

Mitoxantrone Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Mitoxantrone to the World

Between 2022 and 2026, India exported $1.9M worth of mitoxantrone across 110 verified shipments to 35 countries — covering 18% of world markets in the Advanced Oncology segment. The largest destination is NAMIBIA (47.0%). MVL GLOBAL leads with a 47.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049049

Mitoxantrone export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Mitoxantrone export data snapshot — $1.9M · 42 exporters · 35 countriesTransData Nexus · Indian Customs Data

Top Mitoxantrone Exporters from India

42 active exporters · Ranked by export value

View all 42 →

Top Mitoxantrone Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MVL GLOBAL	$887.6K	3	1	47.0%
2	INTAS PHARMACEUTICALS LIMITED

Top Countries Importing Mitoxantrone from India

35 destination markets · Ranked by import value

All 35 countries →

Top Countries Importing Mitoxantrone from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NAMIBIA	$887.6K	47.0%
2	MEXICO	$585.1K	31.0%
3	VENEZUELA	$77.4K	4.1%
4	NETHERLANDS	$72.5K	3.8%
5	TAIWAN	$69.8K	3.7%
6	UZBEKISTAN	$54.5K	2.9%
7	FRANCE	$41.2K	2.2%
8	BELARUS	$24.9K	1.3%
9	CUBA	$21.4K	1.1%
10	PANAMA	$17.3K	0.9%

NAMIBIA is India's largest mitoxantrone export destination, absorbing 47.0% of total exports worth $887.6K. The top 5 importing countries — NAMIBIA, MEXICO, VENEZUELA, NETHERLANDS, TAIWAN — together account for 89.7% of India's total mitoxantrone export value. The remaining 30 destination countries collectively receive the other 10.3%, indicating a focused distribution strategy targeting key markets.

Regulatory Landscape — Mitoxantrone

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the U.S. Food and Drug Administration (FDA) has approved multiple Abbreviated New Drug Applications (ANDAs) for Mitoxantrone, indicating a competitive generic market. The FDA's Orange Book lists these approvals, reflecting the drug's established presence in the U.S. market. No current import alerts or significant regulatory actions against Mitoxantrone have been reported, suggesting compliance with FDA standards. The regulatory pathway for Mitoxantrone involves demonstrating bioequivalence to the reference listed drug, ensuring safety and efficacy. Given the 42 active Indian exporters and the drug's inclusion in the WHO Model List of Essential Medicines, Mitoxantrone's export from India to the U.S. aligns with global health priorities.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), Mitoxantrone requires marketing authorization from the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. These agencies mandate compliance with Good Manufacturing Practice (GMP) standards to ensure product quality and safety. As of March 2026, Mitoxantrone holds marketing authorizations in several EU member states and the UK, reflecting its recognized therapeutic value. Manufacturers exporting to these regions must adhere to stringent regulatory requirements, including periodic inspections and pharmacovigilance obligations.

3WHO Essential Medicines & Global Standards

Mitoxantrone is listed in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, underscoring its importance in treating priority health conditions. This inclusion facilitates its adoption into national essential medicines lists, promoting broader access. While Mitoxantrone is not currently prequalified by the WHO Prequalification Programme, it must comply with international pharmacopoeia standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to ensure consistent quality across markets.

4India Regulatory Classification

In India, Mitoxantrone is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for Mitoxantrone as of March 2026, allowing market-driven pricing. For export, the Central Drugs Standard Control Organization (CDSCO) mandates a No Objection Certificate (NOC), ensuring that domestic supply is not adversely affected by export activities.

5Patent & Exclusivity Status

Mitoxantrone's primary patents have expired, leading to the availability of generic versions and increased market competition. This patent expiration has facilitated the entry of multiple manufacturers, contributing to the drug's affordability and accessibility in various markets.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines updated the Model List to its 24th edition, reaffirming Mitoxantrone's inclusion and highlighting its continued relevance in global health. In September 2025, the WHO published the updated Model List, providing guidance for countries to develop and update their national essential medicines lists. In January 2026, the WHO released a fact sheet emphasizing the importance of essential medicines, including Mitoxantrone, in addressing priority health-care needs. These developments reflect ongoing efforts to ensure the availability and affordability of essential medicines like Mitoxantrone worldwide.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Mitoxantrone

Retail & reference prices across 9 markets vs. India FOB export price of $38.26/unit

Global Price Benchmark for Mitoxantrone across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$15.28 – $35.02	USD	According to the FDA Orange Book, mitoxantrone is an approved drug product.
United Kingdom	Data not available	GBP	Mitoxantrone is listed in the British National Formulary (BNF).
Germany	Data not available	EUR	Mitoxantrone is approved by the European Medicines Agency (EMA).
Australia	Data not available	AUD

Supply Chain Risk Assessment — Mitoxantrone

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Mitoxantrone, an anthracenedione antineoplastic agent, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) is heavily reliant on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in this sector. This dependency poses a significant risk, as any disruption in the Chinese supply chain can directly impact the availability and cost of Mitoxantrone APIs.

Recent environmental regulations and factory shutdowns in China have led to supply uncertainties and increased prices for KSMs. For instance, in 2018, several Chinese chemical plants were closed due to environmental concerns, causing a ripple effect in the global pharmaceutical supply chain. Such events underscore the vulnerability of relying on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters account for 90.6% of Mitoxantrone exports, with MVL Global alone contributing 47.0% of the total export value. This high supplier concentration amplifies the risk of supply disruptions, as any operational or regulatory issues affecting these key players can significantly impact global availability.

Access Complete Mitoxantrone Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 110 transactions across 35 markets.

Request Demo View Pricing

Frequently Asked Questions — Mitoxantrone Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top mitoxantrone exporters from India?

The leading mitoxantrone exporters from India are MVL GLOBAL, INTAS PHARMACEUTICALS LIMITED, MEDWISE OVERSEAS PRIVATE LIMITED, and 6 others. MVL GLOBAL leads with 47.0% market share ($887.6K). The top 5 suppliers together control 90.6% of total export value.

What is the total export value of mitoxantrone from India?

The total export value of mitoxantrone from India is $1.9M, recorded across 110 shipments from 42 active exporters to 35 countries. The average shipment value is $17.2K.

Which countries import mitoxantrone from India?

India exports mitoxantrone to 35 countries. The top importing countries are NAMIBIA (47.0%), MEXICO (31.0%), VENEZUELA (4.1%), NETHERLANDS (3.8%), TAIWAN (3.7%), which together account for 89.7% of total export value.

What is the HS code for mitoxantrone exports from India?

The primary HS code for mitoxantrone exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Mitoxantrone

Mitoxantrone

How India Exports Mitoxantrone to the World

Top Mitoxantrone Exporters from India

Top Countries Importing Mitoxantrone from India

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Mitoxantrone

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Mitoxantrone

Supply Chain Risk Assessment — Mitoxantrone

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Mitoxantrone Trade Intelligence

Frequently Asked Questions — Mitoxantrone Exports from India

Who are the top mitoxantrone exporters from India?

What is the total export value of mitoxantrone from India?

Which countries import mitoxantrone from India?

What is the HS code for mitoxantrone exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of mitoxantrone exports from India?

Which ports handle mitoxantrone exports from India?

Why is India a leading exporter of mitoxantrone?

What certifications do Indian mitoxantrone exporters need?

How many buyers import mitoxantrone from India?

What is the market share of the top mitoxantrone exporter from India?

Analysis Methodology